DK1206448T3 - Nye vitamin D analoger - Google Patents
Nye vitamin D analogerInfo
- Publication number
- DK1206448T3 DK1206448T3 DK00943703T DK00943703T DK1206448T3 DK 1206448 T3 DK1206448 T3 DK 1206448T3 DK 00943703 T DK00943703 T DK 00943703T DK 00943703 T DK00943703 T DK 00943703T DK 1206448 T3 DK1206448 T3 DK 1206448T3
- Authority
- DK
- Denmark
- Prior art keywords
- analogues
- new vitamin
- vitamin
- phenyl
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Analytical Chemistry (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14720099P | 1999-08-04 | 1999-08-04 | |
| PCT/DK2000/000389 WO2001010829A1 (en) | 1999-08-04 | 2000-07-11 | Novel vitamin d analogues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1206448T3 true DK1206448T3 (da) | 2004-08-09 |
Family
ID=22520639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00943703T DK1206448T3 (da) | 1999-08-04 | 2000-07-11 | Nye vitamin D analoger |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6573255B1 (da) |
| EP (1) | EP1206448B1 (da) |
| JP (2) | JP2003506435A (da) |
| KR (1) | KR20020022792A (da) |
| CN (1) | CN1167678C (da) |
| AT (1) | ATE265430T1 (da) |
| AU (1) | AU770771B2 (da) |
| CA (1) | CA2381910A1 (da) |
| CZ (1) | CZ2002392A3 (da) |
| DE (1) | DE60010276T2 (da) |
| DK (1) | DK1206448T3 (da) |
| ES (1) | ES2216908T3 (da) |
| HK (1) | HK1049148B (da) |
| HU (1) | HUP0202305A3 (da) |
| NZ (1) | NZ516913A (da) |
| PL (1) | PL364698A1 (da) |
| PT (1) | PT1206448E (da) |
| RU (1) | RU2228928C2 (da) |
| WO (1) | WO2001010829A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0117645D0 (en) | 2001-07-19 | 2001-09-12 | Isis Innovation | Therapeutic stratergies for prevention and treatment of alzheimers disease |
| WO2005027930A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | 2-alkylene-19-nor-vitamin d derivatives for the treatment of osteosarcoma |
| US20050074443A1 (en) * | 2003-10-03 | 2005-04-07 | Treadwell Benjamin V. | Methods of attenuating autoimmune disease and compositions useful therefor |
| US8404667B2 (en) * | 2006-12-29 | 2013-03-26 | Wisconsin Alumni Research Foundation | Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog |
| KR20100082840A (ko) | 2007-09-27 | 2010-07-20 | 에스체아 히기에너 프로덕츠 악티에볼라그 | 클레이결합된 폴리머 겔 |
| CN103922984B (zh) * | 2014-04-24 | 2016-08-24 | 湖南华腾制药有限公司 | 西奥骨化醇的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5254799A (en) * | 1985-01-18 | 1993-10-19 | Plant Genetic Systems N.V. | Transformation vectors allowing expression of Bacillus thuringiensis endotoxins in plants |
| DE3715114A1 (de) * | 1987-05-06 | 1988-11-17 | Krause Hans | Verfahren und einrichtung zum toxizitaetsnachweis in oberflaechengewaessern sowie in trink- und brauchwasser |
| GB9206648D0 (en) * | 1992-03-26 | 1992-05-06 | Leo Pharm Prod Ltd | Chemical compounds |
| US5665555A (en) * | 1993-12-15 | 1997-09-09 | Academy Of Natural Sciences Of Philadelphia | Method of determining the effect of a test substance on a clone of a Centroptilum triangulifer mayfly |
| KR20010012770A (ko) * | 1997-05-22 | 2001-02-26 | 세파론, 인코포레이티드 | 비타민 ｄ 유사체 및 그 뉴런 효과 |
-
2000
- 2000-07-11 DK DK00943703T patent/DK1206448T3/da active
- 2000-07-11 NZ NZ516913A patent/NZ516913A/en unknown
- 2000-07-11 CZ CZ2002392A patent/CZ2002392A3/cs unknown
- 2000-07-11 AU AU58072/00A patent/AU770771B2/en not_active Ceased
- 2000-07-11 PT PT00943703T patent/PT1206448E/pt unknown
- 2000-07-11 WO PCT/DK2000/000389 patent/WO2001010829A1/en active IP Right Grant
- 2000-07-11 ES ES00943703T patent/ES2216908T3/es not_active Expired - Lifetime
- 2000-07-11 PL PL00364698A patent/PL364698A1/xx not_active Application Discontinuation
- 2000-07-11 US US10/048,363 patent/US6573255B1/en not_active Expired - Fee Related
- 2000-07-11 AT AT00943703T patent/ATE265430T1/de not_active IP Right Cessation
- 2000-07-11 RU RU2002105520/04A patent/RU2228928C2/ru not_active IP Right Cessation
- 2000-07-11 HU HU0202305A patent/HUP0202305A3/hu unknown
- 2000-07-11 CA CA002381910A patent/CA2381910A1/en not_active Abandoned
- 2000-07-11 JP JP2001515296A patent/JP2003506435A/ja active Pending
- 2000-07-11 DE DE60010276T patent/DE60010276T2/de not_active Expired - Fee Related
- 2000-07-11 KR KR1020027001539A patent/KR20020022792A/ko not_active Application Discontinuation
- 2000-07-11 EP EP00943703A patent/EP1206448B1/en not_active Expired - Lifetime
- 2000-07-11 CN CNB008123454A patent/CN1167678C/zh not_active Expired - Fee Related
- 2000-07-31 JP JP2001515324A patent/JP4971571B2/ja not_active Expired - Fee Related
-
2003
- 2003-02-18 HK HK03101142.2A patent/HK1049148B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE265430T1 (de) | 2004-05-15 |
| CN1372544A (zh) | 2002-10-02 |
| AU5807200A (en) | 2001-03-05 |
| AU770771B2 (en) | 2004-03-04 |
| EP1206448B1 (en) | 2004-04-28 |
| PL364698A1 (en) | 2004-12-13 |
| HUP0202305A2 (en) | 2002-10-28 |
| PT1206448E (pt) | 2004-08-31 |
| CN1167678C (zh) | 2004-09-22 |
| US6573255B1 (en) | 2003-06-03 |
| JP2003506067A (ja) | 2003-02-18 |
| DE60010276D1 (de) | 2004-06-03 |
| HUP0202305A3 (en) | 2003-10-28 |
| JP2003506435A (ja) | 2003-02-18 |
| JP4971571B2 (ja) | 2012-07-11 |
| HK1049148B (zh) | 2005-03-11 |
| RU2228928C2 (ru) | 2004-05-20 |
| DE60010276T2 (de) | 2005-04-21 |
| CZ2002392A3 (cs) | 2002-11-13 |
| CA2381910A1 (en) | 2001-02-15 |
| NZ516913A (en) | 2003-11-28 |
| ES2216908T3 (es) | 2004-11-01 |
| WO2001010829A1 (en) | 2001-02-15 |
| HK1049148A1 (en) | 2003-05-02 |
| EP1206448A1 (en) | 2002-05-22 |
| KR20020022792A (ko) | 2002-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1116845T1 (el) | S-φθορομεθυλεστερας του 6.αλφα.,9.αλφα.-διφθορο-17.αλφα.-[(2-φουρανυλοκαρβονυλ)οξυ]-11.βητα.-υδροξυ-16.αλφα.-μεθυλ-3-οξο-ανδροστ-1,4,-διενο-17-καρβοθειοϊκου οξεος ως ενας αντι-φλεγμονωδης παραγοντας | |
| DK0984778T3 (da) | Neuropeptid-Y-ligander | |
| DE69325454T2 (de) | Taxol-derivate | |
| RU2008132204A (ru) | Соединения для лечения метаболических заболеваний | |
| ATE407155T1 (de) | Pyridin-imin polymerisationskatalysator | |
| SG165361A1 (en) | Antituberculous composition comprising oxazole compounds | |
| ES2175989T3 (es) | Derivado de testosterona. | |
| HK1045990A1 (en) | Novel derivatives and analogues of galanthamin. | |
| DE69724646D1 (de) | 16-ene-vitamin d derivate | |
| DK1206448T3 (da) | Nye vitamin D analoger | |
| AR004965A1 (es) | Procedimiento de preparacion de derivados de fenilimidazolidina | |
| EA200000628A1 (ru) | Ингибиторы металлопротеаз матрикса | |
| TR200100740T2 (tr) | Tiyazolilsinnamonitriller ve haşere kontrol edici ajanlar | |
| AP2001002045A0 (en) | FKBP inhibitors. | |
| ATE393807T1 (de) | Alkylbernsteinsäurehydrazid-additive für schmiermittel | |
| DK0963998T3 (da) | Azasteroidforbindelse til behandling eller prævention af prostatacancer | |
| ES8507525A1 (es) | Procedimiento para preparar 3-acil-2-nitrometilentetrahidro-2h-1, 3-tiazinas | |
| TR199901284A2 (xx) | Ester bile�imleri. | |
| DK1140932T3 (da) | Derivater af benzo-1,8-naphtyridin | |
| ECSP961890A (es) | Benzotiofenos lipofilos (caso x- 10395) | |
| DK1119351T3 (da) | Anvendelse af katecholderivater som proteinaseinhibitorer | |
| FI946009A0 (fi) | Ytimenvärjäytymisenestoaineiden käyttö isosyanaattiin perustuvien solumuovien valmistuksessa | |
| BR0109394A (pt) | Compostos de esponja antitumores |